Cheng-zhi Zhou
State Key Laboratory Of Respiratory Disease
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS).
Journal: Nature communications
Published: June 21, 2025
Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired BRAF V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer patients.
Journal: Translational lung cancer research
Published: April 24, 2024
Recurrent pleural effusion as a rare manifestation after prolonged PD1 inhibitor (camrelizumab)-based immunotherapy: A case report.
Journal: Human vaccines & immunotherapeutics
Published: August 02, 2023
Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: February 28, 2021
Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer.
Journal: Frontiers in oncology
Published: January 19, 2021
Anlotinib Plus S-1 for Patients with EGFR Mutation-Negative Advanced Squamous Cell Lung Cancer with PS Scores of 2-3 After Progression of Second-Line or Later-Line Treatment.
Journal: Cancer management and research
Published: August 24, 2020
Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma.
Journal: Orphanet journal of rare diseases
Published: December 31, 2019
The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients.
Journal: Cancer biology & therapy
Published: April 17, 2019
Case report: dermatomyositis associated with lung cancer with heterogeneous morphology.
Journal: Journal of thoracic disease
Published: January 10, 2018
Efficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinoma.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: October 12, 2014
Effect of tiotropium on neural respiratory drive during exercise in severe COPD.
Journal: Pulmonary pharmacology & therapeutics
Published: June 10, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026